## Abstract Head and neck cancer is a challenging disease that is expected to account for greater than 500,000 new cases worldwide in 2008. Toxicity has impeded advances in chemotherapy and radiation for head and neck cancer, and the prognosis for patients with recurrent and/or metastatic disease r
Basic science reviews: Immunomodulation therapy for squamous cell carcinoma of the head and neck
β Scribed by Norris K. Lee; Dr. Giorgio Cortesina; Antonella De Stefani; Manuela Sacchi; Stefano Rosso; Emanuela Galeazzi
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 478 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The role of the immune system in the pathogenesis and treatment of cancer is currently a popular area of research. An underlying fundamental concept of cancer immunology is the supposition that tumor cells express antigens differently than normal cells, both qualitatively and quantitatively. Understanding tumorβhost interactions may suggest opportunities to modify these relationships to obtain antitumor effects. There is growing evidence that the immune system plays an important role in the pathogenesis of squamous cell carcinoma of the head and neck (SCCHN).^1β4^ Based on this evidence, trials studying the therapeutic efficacy of biologic response modifiers (BRMs) have been undertaken. These trials have had variable success, but continued efforts incorporating newer cytokines are underway.
π SIMILAR VOLUMES
Basaloid squamous cell carcinoma (BSCC) of the head and neck is a recently described high-grade variant of squamous cell carcinoma. It is a biologically virulent neoplasm with a propensity for nodal, as well as systemic, metastases. Because of the limited number of published reports, we reviewed dat
## Abstract ## Objectives/Hypothesis: To discuss the role of radiotherapy (RT) in the treatment of cutaneous squamous and basal cell carcinomas of the head and neck. ## Methods: Review of the pertinent literature. ## Results: The likelihood of cure with a good cosmetic outcome is high for pati
## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR
## Abstract ## Background. To define the role of planned neck dissection after definitive radiotherapy for patients with nodeβpositive squamous cell carcinoma of the head and neck. ## Methods. Review of the pertinent literature. ## Results. Radiotherapy alone produces a relatively high likelih